Thursday, 19 November 2026
4 PM GMTJapanese Encephalitis (JE) is a mosquito-borne viral infection found in 25 countries across Asia and the Western Pacific.1,2 As travel patterns evolve, pharmacy professionals play an important role in helping travellers understand the risk of vector-borne diseases and how to reduce exposure. This webinar aims to support healthcare professionals in recognising JE risk within an individualised travel health assessment.
A traveller’s destination, itinerary and activities may influence their exposure to mosquitoes and the risk of JE infection. Understanding the geographic distribution of JE, how the infection is transmitted and which traveller profiles may be at risk can help inform practical prevention discussions.1,2
This webinar will provide practical education to help pharmacy professionals identify relevant JE risk factors, discuss bite-avoidance strategies and incorporate JE considerations into routine travel health consultations.
This webinar explores:
- The global impact and evolving epidemiology of Japanese Encephalitis
- The mosquito vectors responsible for JE transmission
- How travel destinations and itineraries may influence potential exposure
- Key risk factors associated with JE among different traveller profiles
- Practical bite-avoidance measures that can help reduce the risk of infection
- Opportunities to incorporate JE risk assessment into comprehensive travel health consultations
- Approaches to supporting informed, individualised traveller protection discussions
Speaker Details
Derek Evans
Vice Dean at the Faculty of Travel Medicine
Fill out the form now to register!
This promotional webinar is organised and funded by Valneva UK Ltd. and is intended for UK HCPs only. During the webinar, Valneva products will be discussed.
CLICK HERE for IXIARO® prescribing information.
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to the Valneva UK Ltd. Medical Information department on Tel: 01506 446608 or via email: safety@valneva.com
UK-JE-2600026 October 2026
References -
1.) Centers for Disease Control and Prevention. Yellow Book 2026. Section 4: Japanese Encephalitis.
https://www.cdc.gov/yellow-book/hcp/travel-associated-infections-diseases/japanese-encephalitis.html (last accessed October 2026).
2.) Centers for Disease Control and Prevention. Areas at risk for Japanese Encephalitis. February 2026.
https://www.cdc.gov/japanese-encephalitis/data-maps/index.html (last accessed October 2026).
1.) Centers for Disease Control and Prevention. Yellow Book 2026. Section 4: Japanese Encephalitis.
https://www.cdc.gov/yellow-book/hcp/travel-associated-infections-diseases/japanese-encephalitis.html (last accessed October 2026).
2.) Centers for Disease Control and Prevention. Areas at risk for Japanese Encephalitis. February 2026.
https://www.cdc.gov/japanese-encephalitis/data-maps/index.html (last accessed October 2026).
